PARRY, ROMANI, DECONCINI & SYMMS for NOVARTIS CORP
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Copyright/Patent/Trademark CPT
S. 1145, H.R. 1908: Patent Reform Act of 2007. To amend title 35, United States Code, relating to the procurement, enforcement, and validity of patents. Lobbied to protect intellectual property rights. Sought amendments to insure the enforceability of patents.
Foreign entity interest: Novartis AG to the degree that public policies, either laws or regulations, commercially benefit Novartis Corporation, so too Novartis AG, as its parent, will benefit.
| Lobbyist | Covered position, as disclosed |
|---|---|
| EDWARD H BAXTER | — |
| ROMANO ROMANI | — |
| STEVE SYMMS | — |
Health Issues HCR
H.R. 4703, S. 2467, H.R. 4991 - Vaccine Shortage Preparedness Act of 2008 S. 2464, H.R. 4992, H.R. 4704 - A bill to amend title XVIII of the Social Security Act to provide for coverage of federally recommended vaccines under Medicare, Part B S. 2465, H.R. 4702, H.R. 4990 - A bill to amend title XIX of the Social Security Act to include all public clinics for the distribution of pediatric vaccines under the Medicaid program S. 2467, H.R. 4703, H.R. 4991 - a bill to amend the Social Security Act, the Federal Food, Drug and Cosmetic Act, and the Public Health Service Act to ensure a sufficient supply of vaccines and for other purposes Opposed efforts to amend the Federal Food, Drug and Cosmetic Act with respect to the sale of prescription drugs through the internet, and for other purposes. Lobbied to ensure that the Internet would not be used to import counterfeit and defective medical products H.R. 4705 - Vaccines for the Uninsured Adult Act of 2008 S. 3678 - Pandemic All Hazards Preparedness Act (Biodefense) S. 1505 - Affordable Biologics for Consumers Act S. 1695 Biologics Price Competition and Innovation Act of 2007, support enactment and follow-on Biologics legislation with amendments that strengthen FDA pathway and provide data exclusivity H.R. 1956 - Patient Protection and Innovative Biologic Medicines Act of 2007 H.R. 1038 Access to Life-Saving Medicine Act S. 623 - Access to Life-Saving Medicine Act General matters related to vaccine industry stability, pandemic preparedness, avian influenza
Foreign entity interest: Novartis AG to the degree that public policies, either laws or regulations, commercially benefit Novartis Corporation, so too Novartis AG, as its parent, will benefit.
| Lobbyist | Covered position, as disclosed |
|---|---|
| EDWARD H BAXTER | — |
| ROMANO ROMANI | — |
| STEVE SYMMS | — |
Budget/Appropriations BUD
S. 3230 - Appropriations for the Departments of Labor, Health and Human Services, and Education, and Related Agencies for the fiscal year ending September 30, 2009, and for other purposes. Lobby for sufficient funding of the CDC and NIH in the area of vaccines and vaccine development. Supplemental appropriations legislation in the area of funds for domestic vaccine supply, Centers for Disease Control, National Institutes of Health and Vaccine Injury Compensation Fund S. 3604 - National Park Centennial Fund Act (Introduced in Senate). Support funding for pandemic flu preparedness.
Foreign entity interest: Novartis AG to the degree that public policies, either laws or regulations, commercially benefit Novartis Corporation, so too Novartis AG, as its parent, will benefit.
| Lobbyist | Covered position, as disclosed |
|---|---|
| EDWARD H BAXTER | — |
| ROMANO ROMANI | — |
| STEVE SYMMS | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.